FMP
Feb 8, 2024 7:20 PM - Davit Kirakosyan(Last modified: Feb 9, 2024 1:15 AM)
CVS Health (NYSE:CVS) disclosed its fourth-quarter financial results and revised its earnings forecast for 2024 downwards.
In the fourth quarter of 2023, CVS Health announced an earnings per share (EPS) of $2.12, surpassing the analysts' consensus of $1.98. The company's revenue for the quarter was $93.81 billion, exceeding expectations of $90.25 billion.
Revenue from health services reached $49.15 billion, outperforming the anticipated $45.96 billion by analysts.
Looking into the full fiscal year of 2024, CVS Health adjusted its EPS forecast to a minimum of $8.30, a decrease from the previously projected $8.50. This adjustment comes in below the analyst consensus of $8.47.
Jan 16, 2024 4:18 PM - Samuel Abdelshahid
In the hustle and bustle of the trading world, having a trustworthy laptop is like having a reliable partner by your side. Making well-informed decisions and staying ahead of market trends become second nature with the right device. However, the quest for a budget-friendly trading laptop t...
Jan 21, 2024 4:00 AM - Parth Sanghvi
Introduction: In the world of financial analysis, a profound grasp of essential profitability metrics is vital. This blog delves into three pivotal metrics—ROE (Return on Equity), ROA (Return on Assets), and Net Profit Margin—offering clear insights without unnecessary complexity. Exploring RO...
May 14, 2024 11:41 AM - Sanzhi Kobzhan
A stock's target price, also known as its fair value, is an indication of what a share can cost based on the company’s forecasted financial statements. It is important to know a stock's fair value to find undervalued stocks with great growth potential. Let's consider how investment analysts calculat...